News
Important Only
Other
Coya Therapeutics Announces Issuance Of New U.S. Patent Protecting Methods Of Producing Recombinant Human (Rh) Interleukin-2 (Aldesleukin) Liquid Formulations
June 2 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS ANNOUNCES ISSUANCE OF NEW U.S. PATENT PROTECTING METHODS OF PRODUCING RECOMBINANT HUMAN (RH) INTERLEUKIN-2 (ALDESLEUKIN) LIQUID FORMULATIONSCOYA THERAPEUTICS INC - TO SUBMIT IND FOR COYA 302 BY END OF JUNEReuters
Mon, Jun 2
Other
Blueprint Medicines Corp - Sanofi To Pay $500 Mln To Co If Deal Is Terminated Under Certain Circumstances
June 2 (Reuters) - Blueprint Medicines Corp BPMC.O:BLUEPRINT MEDICINES CORP: SANOFI TO PAY $500 MILLION TO CO IF DEAL IS TERMINATED UNDER CERTAIN CIRCUMSTANCESBLUEPRINT MEDICINES CORP: CO TO PAY SANOFI $318 MILLION IF DEAL IS TERMINATED UNDER CERTAIN CIRCUMSTANCESSource text: [ID:n0001104659-25-0551...Reuters
Mon, Jun 2
Other
Simulations Plus To Reduce Workforce By 10% - SEC Filing
June 2 (Reuters) - Simulations Plus Inc SLP.O:SIMULATIONS PLUS INC - TO REDUCE WORKFORCE BY 10% - SEC FILINGSIMULATIONS PLUS INC - EXPECTS $4.3 MILLION ANNUALIZED COST SAVINGS - SEC FILINGSource text: [ID:n0001023459-25-000035]Reuters
Mon, Jun 2
Other
CareTrust REIT Announces $500 Million Term Loan
June 2 (Reuters) - CareTrust REIT Inc CTRE.N:CARETRUST REIT: ADDS NEW $500 MILLION TERM LOAN TO EXISTING $1.2 BILLION UNSECURED REVOLVING CREDIT FACILITYCARETRUST REIT INC - TERM LOAN MATURES IN MAY 2030 WITH $800 MILLION ACCORDION FEATUREReuters
Mon, Jun 2
Other
AES Corp - Argentina Ordered To Pay AES $733 Mln In Damages - SEC Filing
June 2 (Reuters) - AES Corp AES.N:AES CORP - ARGENTINA ORDERED TO PAY AES $733 MILLION IN DAMAGES - SEC FILINGAES CORP - ICSID TRIBUNAL ISSUES ARBITRATION AWARD IN AES'S FAVOR - SEC FILINGSource text: [ID:n0000950103-25-006759]Reuters
Mon, Jun 2
Other
Regeneron Expands Clinical-Stage Obesity Portfolio
June 2 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:REGENERON EXPANDS CLINICAL-STAGE OBESITY PORTFOLIO WITH STRATEGIC IN-LICENSING OF NOVEL DUAL GLP-1/GIP RECEPTOR AGONISTREGENERON PHARMACEUTICALS INC - TO PAY $80 MILLION UPFRONT TO HANSOHREGENERON PHARMACEUTICALS INC: POTENTIAL ADDITIONAL PAYME...Reuters
Mon, Jun 2
Other
Chime Financial - IPO Price Estimated Between $24 And $26 Per Share - SEC Filing
June 2 (Reuters) - Chime Financial Inc CHYM.O:CHIME FINANCIAL INC - IPO PRICE ESTIMATED BETWEEN $24 AND $26 PER SHARE - SEC FILINGCHIME FINANCIAL NOW SEES IPO OF 32 MILLION SHARES OF CLASS A COMMON STOCK- SEC FILINGCHIME FINANCIAL- CEO CHRISTOPHER BRITT TO HOLD 34.7% VOTING POWER, POST OFFERING - SE...Reuters
Mon, Jun 2
